{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:55:17Z","timestamp":1778903717420,"version":"3.51.4"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T00:00:00Z","timestamp":1305072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11154-011-9180-6","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T08:35:16Z","timestamp":1305016516000},"page":"93-106","source":"Crossref","is-referenced-by-count":51,"title":["Update on hormonal contraception and bone density"],"prefix":"10.1007","volume":"12","author":[{"given":"Michelle M.","family":"Isley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Kaunitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,11]]},"reference":[{"key":"9180_CR1","unstructured":"Mosher WD, Jones J. Use of Contraception in the United States: 1982\u20132008. Vital and Health Statistics. Series 23, Number 29, May 2010."},{"key":"9180_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","volume":"70","author":"J Trussell","year":"2004","unstructured":"Trussell J. Contraceptive failure in the United States. Contraception. 2004;70:89\u201396.","journal-title":"Contraception"},{"key":"9180_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21:115\u201337.","journal-title":"Endocr Rev"},{"key":"9180_CR4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.abb.2010.07.006","volume":"503","author":"BL Clarke","year":"2010","unstructured":"Clarke BL, Khosla S. Female reproductive system and bone. Archives of Biochemistry and Biophysics. 2010;503:118\u201328.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"9180_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5122(03)00150-6","volume":"45","author":"J Sirola","year":"2003","unstructured":"Sirola J, Kroger H, Honkanen R, Jurvelin JS, Sandini L, Tuppurainen MT, et al. Factors affecting bone loss around menopause in women without HRT: a prospective study. Maturitas. 2003;45:159\u201367.","journal-title":"Maturitas"},{"key":"9180_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1210\/jc.82.1.57","volume":"82","author":"AM Boot","year":"1997","unstructured":"Boot AM, de Ridder MA, Pols HA, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab. 1997;82:57\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"9180_CR7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2006.01.003","volume":"73","author":"SL Martins","year":"2006","unstructured":"Martins SL, Curtis KM, Glasier AF. Combined hormonal contraception and bone health: a systematic review. Contraception. 2006;73:445\u201369.","journal-title":"Contraception"},{"key":"9180_CR8","first-page":"875","volume":"46","author":"C Castelo-Branco","year":"2001","unstructured":"Castelo-Branco C, Vicente JJ, Pons F, Martinex de Osaba MJ, Casals E, Vanrell JA. Bone mineral density in young, hypothalamic olioamenorrheic women treated with oral contraceptives. J reprod Med. 2001;46:875\u20139.","journal-title":"J reprod Med"},{"key":"9180_CR9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9378(97)70396-X","volume":"176","author":"AC Hergenroeder","year":"1997","unstructured":"Hergenroeder AC, Smith EO, Shypailo R, Jones LA, Klish WJ, Ellis K. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997;176:1017\u201325.","journal-title":"Am J Obstet Gynecol"},{"key":"9180_CR10","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1210\/jc.2003-031334","volume":"89","author":"A Rickenkund","year":"2004","unstructured":"Rickenkund A, Carlstrom K, Ekblom B, Brismar TB, Von SB, Hirschberg AL. Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinal Metab. 2004;89:4364\u201370.","journal-title":"J Clin Endocrinal Metab"},{"key":"9180_CR11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/jbmr.5650071215","volume":"7","author":"E Seeman","year":"1992","unstructured":"Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res. 1992;7:1467\u201374.","journal-title":"J Bone Miner Res"},{"key":"9180_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajog.2004.07.041","volume":"192","author":"BA Cromer","year":"2005","unstructured":"Cromer BA, Lazebnik R, Rome E, Bonny A, Ziegler J, Debanne SM. Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. Am J Obstet Gynecol. 2005;192:42\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"9180_CR13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/jc.2002-020874","volume":"88","author":"T Cundy","year":"2003","unstructured":"Cundy T, Ames R, Horne A, Roberts H, Gamble G, Reid IR. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate. J Clin Endocrinol Metab. 2003;88:78\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9180_CR14","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/humrep\/deg315","volume":"18","author":"M Doren","year":"2003","unstructured":"Doren M, Nilsson J, Johnell O. Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis. Hum Reprod. 2003;18:1737\u201346.","journal-title":"Hum Reprod"},{"key":"9180_CR15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1359\/jbmr.090402","volume":"24","author":"NB Watts","year":"2009","unstructured":"Watts NB, Ettinger B, LeBoff MS. Perspective: FRAX Facts. J Bone Min Research. 2009;24:975\u20139.","journal-title":"J Bone Min Research"},{"key":"9180_CR16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","volume":"332","author":"SR Cummings","year":"1995","unstructured":"Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767\u201373.","journal-title":"N Engl J Med"},{"key":"9180_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11914-005-0005-y","volume":"3","author":"MR McClung","year":"2005","unstructured":"McClung MR. The relationship between bone mineral density and fracture risk. Curr Osteoporos Rep. 2005;3:57\u201363.","journal-title":"Curr Osteoporos Rep"},{"key":"9180_CR18","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","volume":"81","author":"SL Hui","year":"1988","unstructured":"Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804\u20139.","journal-title":"J Clin Invest"},{"key":"9180_CR19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","volume":"105","author":"DA Grimes","year":"2005","unstructured":"Grimes DA, Schulz KF. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol. 2005;105:1114\u20138.","journal-title":"Obstet Gynecol"},{"key":"9180_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1185\/030079903125003062","volume":"20","author":"CA Cefalu","year":"2004","unstructured":"Cefalu CA. Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin. 2004;20:341\u20139.","journal-title":"Curr Med Res Opin"},{"key":"9180_CR21","unstructured":"Speroff L, Darney PD. Special uses of oral contraception. In: A clinical guide for contraception. Philadelphia. Lippincott Williams & Wilkins, 2005, p 144, PA"},{"key":"9180_CR22","first-page":"381","volume":"41","author":"DR Mishell Jr","year":"1996","unstructured":"Mishell Jr DR. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41:381\u201390.","journal-title":"J Reprod Med"},{"key":"9180_CR23","unstructured":"Speroff L, Darney PD. Implant contraception. In: A Clinical Guide for Contraception. Philadelphia. PA: Lippincott Williams & Wilkins, 2005, p 166"},{"key":"9180_CR24","unstructured":"Speroff L, Darney PD. Intrauterine contraception. In: A Clinical Guide for Contraception. Philadelphia. PA: Lippincott Williams & Wilkins, 2005, p 228"},{"key":"9180_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07853899009147248","volume":"22","author":"T Luukkainen","year":"1990","unstructured":"Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasong intrauterine device. Ann Med. 1990;22:85\u201390.","journal-title":"Ann Med"},{"key":"9180_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/15.1.118","volume":"15","author":"R Beerthuizen","year":"2000","unstructured":"Beerthuizen R, Van Beek A, Massai R, Makarainen L, Hout J, Bennink HC. Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a nonhormonal method of contraception. Hum Reprod. 2000;15:118\u201322.","journal-title":"Hum Reprod"},{"key":"9180_CR27","unstructured":"Speroff L, Darney PD. Oral contraception. In: A Clinical Guide for Contraception. Philadelphia. PA: Lippincott Williams & Wilkins, 2005, p 41"},{"key":"9180_CR28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2007.11.005","volume":"77","author":"MA Vandever","year":"2008","unstructured":"Vandever MA, Kuehl TJ, Sulak PJ, Witt I, Coffee A, Wincek TJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception. 2008;77:162\u201370.","journal-title":"Contraception"},{"key":"9180_CR29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/AOG.0b013e3181e79440","volume":"116","author":"C Westhoff","year":"2010","unstructured":"Westhoff C, Torgal AH, Mayeda ER, Satnczyk FZ, Lerner JP, Benn EK, et al. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol. 2010;116:275\u201383.","journal-title":"Obstet Gynecol"},{"key":"9180_CR30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/GCO.0b013e3282ef1cd2","volume":"19","author":"LL Tolaymat","year":"2007","unstructured":"Tolaymat LL, Kaunitz AM. Long acting contraceptives in adolescents. Curr Opin Obstet Gynecol. 2007;19:453\u201360.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"9180_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jadohealth.2006.11.005","volume":"40","author":"AM Kaunitz","year":"2007","unstructured":"Kaunitz AM. Long acting hormonal contraceptives indispensable in preventing teen pregnancy. J Adolesc Health. 2007;40:1\u20133.","journal-title":"J Adolesc Health"},{"key":"9180_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","volume":"159","author":"D Scholes","year":"2005","unstructured":"Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatrc Adolesc Med. 2005;159:139\u201344.","journal-title":"Arch Pediatrc Adolesc Med"},{"key":"9180_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.contraception.2007.08.010","volume":"76","author":"L Rosenberg","year":"2007","unstructured":"Rosenberg L, Zhang Y, Constant D, Cooper D, Kalla AA, Micklesfield L, et al. Bone status after cessation of use of injectable progestin contraceptives. Contraception. 2007;76:425\u201331.","journal-title":"Contraception"},{"key":"9180_CR34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.fertnstert.2007.10.070","volume":"90","author":"BA Cromer","year":"2008","unstructured":"Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Fertil Steril. 2008;90:2060\u20137.","journal-title":"Fertil Steril"},{"key":"9180_CR35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AOG.0b013e3181875b78","volume":"112","author":"AB Berenson","year":"2008","unstructured":"Berenson AB, Rahman M, Breitkopf CR, Bi LX. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet Gynecol. 2008;112:788\u201399.","journal-title":"Obstet Gynecol"},{"key":"9180_CR36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","volume":"81","author":"Z Harel","year":"2010","unstructured":"Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception. 2010;81:281\u201391.","journal-title":"Contraception"},{"key":"9180_CR37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.303.6793.13","volume":"303","author":"T Cundy","year":"1991","unstructured":"Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ. 1991;303:13\u20136.","journal-title":"BMJ"},{"key":"9180_CR38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/bmj.308.6923.247","volume":"308","author":"T Cundy","year":"1994","unstructured":"Cundy T, Cornish J, Evans MC, Roberts H, Reid IR. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ. 1994;308:247\u20138.","journal-title":"BMJ"},{"key":"9180_CR39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0029-7844(98)00447-5","volume":"93","author":"D Scholes","year":"1999","unstructured":"Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol. 1999;93:233\u20138.","journal-title":"Obstet Gynecol"},{"key":"9180_CR40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00001648-200211000-00030","volume":"13","author":"D Scholes","year":"2002","unstructured":"Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002;13:749.","journal-title":"Epidemiology"},{"key":"9180_CR41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","volume":"74","author":"AM Kaunitz","year":"2006","unstructured":"Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25\u201335\u00a0years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception. 2006;74:90\u20139.","journal-title":"Contraception"},{"key":"9180_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","volume":"77","author":"AM Kaunitz","year":"2008","unstructured":"Kaunitz AM, Arias R, McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception. 2008;77:67\u201376.","journal-title":"Contraception"},{"key":"9180_CR43","doi-asserted-by":"crossref","unstructured":"Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. Contraception: article in press, published online September 14, 2010","DOI":"10.1016\/j.contraception.2010.07.027"},{"key":"9180_CR44","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1471-0528.1998.tb10211.x","volume":"105","author":"B Gbolade","year":"1998","unstructured":"Gbolade B, Ellis S, Murby B, Randall S, Kirkman R. Bone density in long term users of depot medroxyprogesterone acetate. Br J Obstet Gynaecol. 1998;105:790\u20134.","journal-title":"Br J Obstet Gynaecol"},{"key":"9180_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(98)00144-9","volume":"59","author":"OS Tang","year":"1999","unstructured":"Tang OS, Tang G, Yip P, Li B, Fan S. Long-term depot medroxyprogesterone acetate and bone mineral density. Contraception. 1999;59:25\u20139.","journal-title":"Contraception"},{"key":"9180_CR46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(00)00168-2","volume":"62","author":"OS Tang","year":"2000","unstructured":"Tang OS, Tang G, Yip PS, Li B. Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study. Contraception. 2000;62:161\u20134.","journal-title":"Contraception"},{"key":"9180_CR47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.contraception.2004.09.003","volume":"71","author":"ME Besinska","year":"2005","unstructured":"Besinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F. Bone mineral density in women aged 40\u201349\u00a0years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Contraception. 2005;71:170\u20135.","journal-title":"Contraception"},{"key":"9180_CR48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1067\/mob.2002.122420","volume":"186","author":"T Cundy","year":"2002","unstructured":"Cundy T, Cornish J, Roberts H, Reid IR. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception. Am J Obstet Gynecol. 2002;186:978\u201383.","journal-title":"Am J Obstet Gynecol"},{"key":"9180_CR49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.contraception.2008.07.013","volume":"78","author":"L Sanches","year":"2008","unstructured":"Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L. Forearm bone density in postmenopausal former users of depot medroxyprogesterone acetate. Contraception. 2008;78:365\u20139.","journal-title":"Contraception"},{"key":"9180_CR50","unstructured":"Viola AS, Castro S, Marchi NM, Bahamondes BV, Viola CF, Bahamondes L. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate. Contraception, In press"},{"key":"9180_CR51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2265.1998.00582.x","volume":"49","author":"BJ Orr-Walker","year":"1998","unstructured":"Orr-Walker BJ, Eveans MC, Ames RW, Clearwater JM, Cundy T, Reid IR. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. Clin Endocrinol. 1998;49:615\u20138.","journal-title":"Clin Endocrinol"},{"key":"9180_CR52","first-page":"309","volume":"44","author":"GJ Harkins","year":"1999","unstructured":"Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report. J Reprod Med. 1999;44:309\u201312.","journal-title":"J Reprod Med"},{"key":"9180_CR53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1783\/1471189054483726","volume":"31","author":"ES Searle","year":"2005","unstructured":"Searle ES. Spinal fracture in a young Depo-Provera user. J Fam Plann Reprod Health Care. 2005;31:255.","journal-title":"J Fam Plann Reprod Health Care"},{"key":"9180_CR54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.whi.2006.09.003","volume":"16","author":"KC Watson","year":"2006","unstructured":"Watson KC, Lentz MJ, Cain KC. Associations between fracture incidence and use of depot medroxyprogesterone acetate and antiepileptic drugs in women with developmental disabilities. Womens Health Issues. 2006;16:346\u201352.","journal-title":"Womens Health Issues"},{"key":"9180_CR55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s001980170155","volume":"12","author":"JM Lappe","year":"2001","unstructured":"Lappe JM, Stegman MR, Recker RR. The impact of lifestyle factors on stress fractures in female army recruits. Osteoporos Int. 2001;12:35\u201342.","journal-title":"Osteoporos Int"},{"key":"9180_CR56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","volume":"78","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. Contraception. 2008;78:459\u201364.","journal-title":"Contraception"},{"key":"9180_CR57","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1210\/jc.2010-0032","volume":"95","author":"C Meier","year":"2010","unstructured":"Meier C, Brauchli YB, Jick SS, Kraenzlin ME, Meier CR. Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrin Metab. 2010;95:4909\u201316.","journal-title":"J Clin Endocrin Metab"},{"key":"9180_CR58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0010-7824(95)00036-A","volume":"51","author":"F Polatti","year":"1995","unstructured":"Polatti F, Perotti F, Filippa N, Gallina D, Nappi RE. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995;51:221\u20134.","journal-title":"Contraception"},{"key":"9180_CR59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","volume":"129","author":"BA Cromer","year":"1996","unstructured":"Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. 1996;129:671\u20136.","journal-title":"J Pediatr"},{"key":"9180_CR60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","volume":"35","author":"BA Cromer","year":"2004","unstructured":"Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort or adolescent girls. J Adolesc Health. 2004;35:434\u201341.","journal-title":"J Adolesc Health"},{"key":"9180_CR61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpag.2003.11.017","volume":"17","author":"E Lara-Torre","year":"2004","unstructured":"Lara-Torre E, Edwards CP, Perlman S, Hertweck SP. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2004;17:17\u201321.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"9180_CR62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bone.2006.08.001","volume":"40","author":"M Hartard","year":"2007","unstructured":"Hartard M, Kleinmond C, Wiseman M, Weissenbacher ER, Felsenberg D, Erben RG. Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone. 2007;40:444\u201350.","journal-title":"Bone"},{"key":"9180_CR63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.contraception.2008.05.002","volume":"78","author":"E Pikkaranainen","year":"2008","unstructured":"Pikkaranainen E, Lehtonen-Veromaa M, Mottonen T, Kautiainen H, Viikara J. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study. Contraception. 2008;78:226\u201331.","journal-title":"Contraception"},{"key":"9180_CR64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.contraception.2008.11.009","volume":"79","author":"ME Beksinska","year":"2009","unstructured":"Beksinska ME, Kleinschmidt I, Smit JA, Farley TM. Bone mineral density in a cohort of adolescents during use of norethondrone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception. 2009;79:345\u20139.","journal-title":"Contraception"},{"key":"9180_CR65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0010-7824(03)00025-8","volume":"67","author":"C Nappi","year":"2003","unstructured":"Nappi C, Di Spiezio SA, Acunzo G, Bifulco G, Tommaselli GA, Guida M, et al. Effects of a low-dose and ultra-low-dose combined contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception. 2003;67:355\u20139.","journal-title":"Contraception"},{"key":"9180_CR66","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2008.01.016","volume":"78","author":"V Gargano","year":"2008","unstructured":"Gargano V, Massaro M, Morra I, Formisano C, Di Carlo C, Nappi C. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception. 2008;78:10\u20135.","journal-title":"Contraception"},{"key":"9180_CR67","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13625180902838828","volume":"14","author":"M Lattakova","year":"2009","unstructured":"Lattakova M, Borovsky M, Payer J, Killinger Z. Oral contraception usage in relation to bone mineral density and boner turnover in adolescent girls. Eur J Contracept Reprod Health Care. 2009;14:207\u201314.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"9180_CR68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.contraception.2009.07.001","volume":"81","author":"D Scholes","year":"2010","unstructured":"Scholes D, Ichikawa L, LaCroix AZ, Spangler L, Beasley JM, Reed S, et al. Oral contraceptive use and bone density in adolescent and young adult women. Contraception. 2010;81:35\u201340.","journal-title":"Contraception"},{"key":"9180_CR69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.AOG.0000148344.26475.fc","volume":"105","author":"C Nappi","year":"2005","unstructured":"Nappi C, Di Spiezio SA, Greco E, Tommaselli GA, Giordano E, Guida M. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol. 2005;105:53\u201360.","journal-title":"Obstet Gynecol"},{"key":"9180_CR70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0010-7824(03)00147-1","volume":"68","author":"SD Reed","year":"2003","unstructured":"Reed SD, Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception. 2003;68:177\u201382.","journal-title":"Contraception"},{"key":"9180_CR71","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0029-7844(01)01495-8","volume":"98","author":"AB Berenson","year":"2001","unstructured":"Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol. 2001;98:576\u201382.","journal-title":"Obstet Gynecol"},{"key":"9180_CR72","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/01.AOG.0000117082.49490.d5","volume":"103","author":"AB Berenson","year":"2004","unstructured":"Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A. Effects of hormonal contraception on bone density after 24\u00a0months of use. Obstet Gynecol. 2004;103:899\u2013906.","journal-title":"Obstet Gynecol"},{"key":"9180_CR73","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s001980200123","volume":"13","author":"KL Cobb","year":"2002","unstructured":"Cobb KL, Kelsey JL, Sidney S, Ettinger B, Lewis CE. Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults. Osteoporos Int. 2002;13:893\u2013900.","journal-title":"Osteoporos Int"},{"key":"9180_CR74","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ajcn\/53.1.132","volume":"53","author":"RB Mazess","year":"1991","unstructured":"Mazess RB, Barden HS. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth control pills. Am J Clin Nutr. 1991;53:132\u201342.","journal-title":"Am J Clin Nutr"},{"key":"9180_CR75","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2004.04.004","volume":"70","author":"AM Paoletti","year":"2004","unstructured":"Paoletti AM, Orru M, Lello S, Floris S, Ranuzzi F, Etzi R, et al. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3\u00a0mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women. Contraception. 2004;70:293\u20138.","journal-title":"Contraception"},{"key":"9180_CR76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/13625189709167466","volume":"2","author":"A Volpe","year":"1997","unstructured":"Volpe A, Amram A, Cagnacci A, Battaglia C. Biochemical aspects of hormonal contraception: effects on bone metabolism. Eyr J Contracept Reprod Health Care. 1997;2:123\u20136.","journal-title":"Eyr J Contracept Reprod Health Care"},{"key":"9180_CR77","first-page":"18","volume":"30","author":"AA Shargil","year":"1985","unstructured":"Shargil AA. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound; a three-year prospective study. Int J Fertil. 1985;30:18\u201328.","journal-title":"Int J Fertil"},{"key":"9180_CR78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s001980070099","volume":"11","author":"M Gambacciani","year":"2000","unstructured":"Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporos Int. 2000;11:544\u20138.","journal-title":"Osteoporos Int"},{"key":"9180_CR79","first-page":"43","volume":"6","author":"M Gambacciani","year":"1999","unstructured":"Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics. Menopause. 1999;6:43\u20138.","journal-title":"Menopause"},{"key":"9180_CR80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5122(94)90062-0","volume":"19","author":"M Gambacciani","year":"1994","unstructured":"Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Maffei S, Piaggesi L, et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism. Maturitas. 1994;19:125\u201331.","journal-title":"Maturitas"},{"key":"9180_CR81","first-page":"392","volume":"83","author":"M Gambacciani","year":"1994","unstructured":"Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol. 1994;83:392\u20136.","journal-title":"Obstet Gynecol"},{"key":"9180_CR82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.maturitas.2005.10.007","volume":"54","author":"M Gambacciani","year":"2006","unstructured":"Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density. Maturitas. 2006;54:176\u201380.","journal-title":"Maturitas"},{"key":"9180_CR83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0378-5122(88)90103-X","volume":"9","author":"H Enzelsberger","year":"1988","unstructured":"Enzelsberger H, Metka M, Heytmanek G, Schurz B, Kurz C, Kusztrich M. Influence of oral contraceptive use on bone density in climacteric women. Maturitas. 1988;9:375\u20138.","journal-title":"Maturitas"},{"key":"9180_CR84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01623231","volume":"4","author":"M Tuppurainen","year":"1994","unstructured":"Tuppurainen M, Kroger H, Saarikoski S, Honkanen R, Alhava E. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int. 1994;4:93\u20138.","journal-title":"Osteoporos Int"},{"key":"9180_CR85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s002239900525","volume":"63","author":"P Masaryk","year":"1998","unstructured":"Masaryk P, Lunt M, Benevolenskaya L, Cannata J, Dequeker J, Dohenhof C, et al. Effects of menstrual history and use of medications on bone mineral density: the EVOS study. Calcif Tissue Int. 1998;63:271\u20136.","journal-title":"Calcif Tissue Int"},{"key":"9180_CR86","first-page":"105","volume":"39","author":"JA Fortney","year":"1994","unstructured":"Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE. Bone mineral density and history of oral contraceptive use. J Reprod Med. 1994;39:105\u20139.","journal-title":"J Reprod Med"},{"key":"9180_CR87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(93)90040-E","volume":"47","author":"A Volpe","year":"1993","unstructured":"Volpe A, Silferi M, Genazzani AD, Genazzani AR. Contraception in olsder women. Contraception. 1993;47:229\u201339.","journal-title":"Contraception"},{"key":"9180_CR88","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(98)09044-8","volume":"353","author":"K Michaelsson","year":"1999","unstructured":"Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S. Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet. 1999;353:1481\u20134.","journal-title":"Lancet"},{"key":"9180_CR89","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fertnstert.2005.01.132","volume":"84","author":"D Barad","year":"2005","unstructured":"Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB. Prior oral contraception and postmenopausal fracture: a Women\u2019s Health Initiative observational cohort. Fertil Steril. 2005;84:374\u201383.","journal-title":"Fertil Steril"},{"key":"9180_CR90","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/humrep\/dei117","volume":"20","author":"R Massai","year":"2005","unstructured":"Massai R, Makarainen L, Kuukankorpi A, Duijkers I, Dieben T. The combined contraceptive vaginal ring and bone density in healthy pre-menopausal women. Hum Reprod. 2005;20:2764\u20138.","journal-title":"Hum Reprod"},{"key":"9180_CR91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.contraception.2009.09.011","volume":"81","author":"M Massaro","year":"2010","unstructured":"Massaro M, Di Carlo C, Gargano V, Formisano C, Bifulco G, Nappi C. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception. 2010;81:209\u201314.","journal-title":"Contraception"},{"key":"9180_CR92","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2009.04.008","volume":"23","author":"Z Harel","year":"2010","unstructured":"Harel Z, Riggs S, Vaz R, Flanagan P, Harel D, Machan JT. Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study. J Pediatr Adolesc Gynecol. 2010;23:23\u201331.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"9180_CR93","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2265.1994.tb02788.x","volume":"41","author":"LE Caird","year":"1994","unstructured":"Caird LE, Reid-Thomas V, Hannan WJ, Gow S, Glasier AF. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women. Clin Endocrinol. 1994;41:739\u201345.","journal-title":"Clin Endocrinol"},{"key":"9180_CR94","doi-asserted-by":"crossref","unstructured":"Wei S, Jones G, Thomson R, Dwyer T, Venn A. Oral contraceptive use and bone mass in women aged 26\u201336\u00a0years. Osteoporos Int: published online February 27, 2010.","DOI":"10.1007\/s00198-010-1180-y"},{"key":"9180_CR95","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/humrep\/dei457","volume":"21","author":"L Bahamondes","year":"2006","unstructured":"Bahamondes L, Espejo-Arce X, Hidalgo MM, Hidalgo-Regina C, Teatin-Juliato C, Petta CA. A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system. Hum Reprod. 2006;21:1316\u20139.","journal-title":"Hum Reprod"},{"key":"9180_CR96","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/humrep\/deq043","volume":"25","author":"MV Bahamondes","year":"2010","unstructured":"Bahamondes MV, Monteiro I, Castro S, Espejo-Arce X, Bahamondes L. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system. Hum Reprod. 2010;25:1158\u201364.","journal-title":"Hum Reprod"},{"key":"9180_CR97","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","volume":"21","author":"L Bahamondes","year":"2006","unstructured":"Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, Dos Santas Fernandes AM, Lui-Filho JF, Perrotti M, et al. A prospective study of the forearm bone density of users of etonogesterl- and levonorgestrel-releasing contraceptive implants. Hum Reprod. 2006;21:466\u201370.","journal-title":"Hum Reprod"},{"key":"9180_CR98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2010.01.018","volume":"109","author":"S Pongsatha","year":"2010","unstructured":"Pongsatha S, Ekmahachai M, Suntornlimsiri N. Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2\u00a0years. Int J Gynecol Obstet. 2010;109:223\u20135.","journal-title":"Int J Gynecol Obstet"},{"key":"9180_CR99","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0029-7844(95)00083-4","volume":"86","author":"HJ Kalkwarf","year":"1995","unstructured":"Kalkwarf HJ, Specker BL. Bone mineral loss during lactation and recovery after weaning. Obstet Gynecol. 1995;86:26\u201332.","journal-title":"Obstet Gynecol"},{"key":"9180_CR100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0029-7844(99)00236-7","volume":"94","author":"F Polatti","year":"1999","unstructured":"Polatti F, Capuzzo E, Viazzo F, Colleoni R, Klersy C. Bone mineral density changes during and after lactation. Obstet Gynecol. 1999;94:52\u20136.","journal-title":"Obstet Gynecol"},{"key":"9180_CR101","first-page":"588","volume":"73","author":"CC Hayslip","year":"1989","unstructured":"Hayslip CC, Klein TA, Wray HL, Duncan WE. The effects of lactation on bone mineral content in healthy postpartum women. Obstet Gynecol. 1989;73:588\u201392.","journal-title":"Obstet Gynecol"},{"key":"9180_CR102","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s001980170033","volume":"12","author":"C Karlsson","year":"2001","unstructured":"Karlsson C, Obrant KJ, Karlsson M. Pregnancy and lactation confer reversible bone loss in humans. Osteoporosis Int. 2001;12:828\u201334.","journal-title":"Osteoporosis Int"},{"key":"9180_CR103","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archpedi.158.7.650","volume":"158","author":"CJ Chantry","year":"2004","unstructured":"Chantry CJ, Auinger P, Byrd RS. Lactation among adolescent mothers and subsequent bone mineral density. Arch Pediatrc Adolesc Med. 2004;158:650\u201371.","journal-title":"Arch Pediatrc Adolesc Med"},{"key":"9180_CR104","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0020-7292(98)00155-6","volume":"63","author":"A Honda","year":"1998","unstructured":"Honda A, Kurabayashi T, Yahata T, Tomita M, Takakuwa K, Tanaka K. Lumbar bone mineral density changes during pregnancy and lactation. Int J Gynecol Obstet. 1998;63:253\u20138.","journal-title":"Int J Gynecol Obstet"},{"key":"9180_CR105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01623940","volume":"6","author":"JM Lopez","year":"1996","unstructured":"Lopez JM, Gonzalez G, Reyes V, Campino C, Diaz S. Bone turnover and density in healthy women during breastfeeding and after weaning. Osteoporosis Int. 1996;6:153\u20139.","journal-title":"Osteoporosis Int"},{"key":"9180_CR106","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1001\/jama.269.24.3130","volume":"269","author":"M Sowers","year":"1993","unstructured":"Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, et al. Changes in bone density with lactation. JAMA. 1993;269:3130\u20135.","journal-title":"JAMA"},{"key":"9180_CR107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6874-9-19","volume":"9","author":"J Lenora","year":"2009","unstructured":"Lenora J, Lekamwasam S, Karlsson MK. Effects of multiparity and prolonged breast-feeding on maternal bone mineral density: a community-based cross-sectional study. BMC Women\u2019s Health. 2009;9:19.","journal-title":"BMC Women\u2019s Health"},{"key":"9180_CR108","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/gme.0b013e3181e0efb3","volume":"17","author":"PF Schnatz","year":"2010","unstructured":"Schnatz PF, Barker KG, Marakovits KA, O\u2019Sullivan DM. Effects of age at first pregnancy and breast-feeding on the development of postmenopausal osteoporosis. Menopause. 2010;17:1161\u20136.","journal-title":"Menopause"},{"key":"9180_CR109","unstructured":"US Food and Drug Administration. Black box warning added concerning long-term use of Depo-Provera Contraceptive Injection, 2004"},{"key":"9180_CR110","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.contraception.2008.07.022","volume":"78","author":"S Paschall","year":"2008","unstructured":"Paschall S, Kaunitz AM. Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians. Contraception. 2008;78:370\u20136.","journal-title":"Contraception"},{"key":"9180_CR111","unstructured":"World Health Organization. WHO statement on hormonal contraception and bone health. WHO Epidemiological Record No 35. Geneva, Switzerland: World Health Organization 2005"},{"key":"9180_CR112","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jadohealth.2006.03.011","volume":"39","author":"BA Cromer","year":"2006","unstructured":"Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM, et al. Depot medroxyprogesterone acetate and bone mineral density in adolescent\u2014the Black Box Warning: a position paper of the Society for Adolescent Medicine. J Adolesc Health. 2006;39:296\u2013301.","journal-title":"J Adolesc Health"},{"key":"9180_CR113","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e318188d1ec","volume":"112","author":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice","year":"2008","unstructured":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 415: depot medroxyprogesterone acetate and bone effects. Obstet Gynecol. 2008;112:727\u201330.","journal-title":"Obstet Gynecol"},{"key":"9180_CR114","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1701-2163(16)32125-9","volume":"28","author":"A Black","year":"2006","unstructured":"Black A. Canadian contraception consensus: update on depot medroxyprogesterone acetate (DMPA). J Obstet Gynaecol Can. 2006;28:305\u201313.","journal-title":"J Obstet Gynaecol Can"},{"key":"9180_CR115","volume-title":"Medical eligibility criteria for contraceptive use","author":"WHO","year":"2009","unstructured":"WHO. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO; 2009.","edition":"4"},{"key":"9180_CR116","volume-title":"Medical eligibility criteria contraceptive use, 2010. Adapted from the WHO Medical eligibility criteria for contraceptive use","author":"CDC","year":"2010","unstructured":"CDC. Medical eligibility criteria contraceptive use, 2010. Adapted from the WHO Medical eligibility criteria for contraceptive use. 4th ed. Atlanta: CDC; 2010.","edition":"4"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-011-9180-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9180-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T17:29:39Z","timestamp":1560187779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-011-9180-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,11]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9180"],"URL":"https:\/\/doi.org\/10.1007\/s11154-011-9180-6","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,11]]}}}